Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed
- 31 August 2005
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 33 (8), 920-927
- https://doi.org/10.1016/j.exphem.2005.05.009
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphomaBlood, 2004
- Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesBlood, 2004
- BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patientsBlood, 2004
- Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipientsBone Marrow Transplantation, 2003
- Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disordersBlood, 2002
- The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantationBlood, 2002
- Allogeneic peripheral blood stem cell transplantation with reduced‐intensity conditioning: results of a prospective multicentre studyBritish Journal of Haematology, 2001
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Repopulation of blood lymphocyte sub‐populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH‐1HImmunology, 1996